SE OF CITICOLINE DRUG IN TREATMENT OF AMBLYOPIA .OR LAZY EYE ASSOCIATED WITH IMPAIRED VISIO
Not Applicable
- Conditions
- Health Condition 1: H479- Unspecified disorder of visual pathways
- Registration Number
- CTRI/2018/09/015653
- Lead Sponsor
- VISHAL DEV
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
PATIENTS WITH ANISOMETROPIC AND STRABISMIC AMBLYOPIA .
MODERATE AMBLYOPIA 6/60 to 6/18 .
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CVA <br/ ><br>BCVA <br/ ><br>CYCLOPLEGIC REFRACTION <br/ ><br>DISTANCE STEREOACUITY <br/ ><br>NEAR STEREOACUITY <br/ ><br>COLOR VISION <br/ ><br>SIDE EFFECTSTimepoint: 1,2,3,4,6 MONTHS
- Secondary Outcome Measures
Name Time Method CVA <br/ ><br>BCVA <br/ ><br>Cycloplegic refractionTimepoint: AT 6 MONTHS